Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk

Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk

Non-alcoholic fatty liver disease is associated with an increased risk of metabolic and cardiovascular diseases. Whether the severity of fatty liver on ultrasound correlates with metabolic or cardiovascular risk remains unclear. A total of 1000 people receiving health examinations were enrolled, and...

Full description

Bibliographic Details
Main Authors:	Chia-Chi Wang, Tai-Chung Tseng, Tsung-Cheng Hsieh, Ching-Sheng Hsu, Pin-Chao Wang, Hans Hsienhong Lin, Jia-Horng Kao
Format:	Article
Language:	English
Published:	Wiley 2012-03-01
Series:	Kaohsiung Journal of Medical Sciences
Subjects:	Cardiovascular disease Diabetes mellitus Non-alcoholic fatty liver disease (NAFLD) Metabolic syndrome Ultrasound
Online Access:	http://www.sciencedirect.com/science/article/pii/S1607551X11002282

Similar Items

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
by: Shun Ishido, et al.
Published: (2023-06-01)

Correlates of ultrasound diagnosed non alcoholic fatty liver disease in Indian adults with features of metabolic syndrome
by: Imran Nazir Salroo, et al.
Published: (2020-03-01)

Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?
by: Angeliki Papachristodoulou, et al.
Published: (2021-06-01)

Predictive Value of Having Positive Family History of Cardiovascular Disorders, Diabetes Mellitus, Dyslipidemia, and Hypertension in Non-Alcoholic Fatty Liver Disease Patients
by: Hossein Khedmat, et al.
Published: (2013-05-01)

Predictive Value of Having Positive Family History of Cardiovascular Disorders, Diabetes Mellitus, Dyslipidemia, and Hypertension in Non-Alcoholic Fatty Liver Disease Patients
by: Mohammad Ebrahim Ghamar-Chehreh, et al.
Published: (2013-05-01)

Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review
by: Abdulrahman Ismaiel, et al.
Published: (2019-09-01)

The Evaluation of the Effect of Hypothyroidism Treatment on Non-Alcoholic Fatty Liver Disease
by: Seyed Alireza Ebadi, et al.
Published: (2021-03-01)

The beneficial effects of taurine in alleviating fatty liver disease
by: Qi Song, et al.
Published: (2021-02-01)

Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2023-09-01)

Factors associated with nonalcoholic fatty liver disease grades detected by ultrasound at a screening center in Klang Valley, Malaysia.
by: Abdul Sattar A. Khammas, et al.
Published: (2018-04-01)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
by: Clarissa Elysia Fu, et al.
Published: (2022-09-01)

Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
by: Kun-Lin Cheng, et al.
Published: (2024-01-01)

Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk NonAlcoholic Fatty Liver Dise
by: Muhammad Nasir Naeem Khan, et al.
Published: (2023-08-01)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
by: Francisco Idalsoaga, et al.
Published: (2020-08-01)

Different risk factors between reflux symptoms and mucosal injury in gastroesophageal reflux disease
by: Chung-Hsien Li, et al.
Published: (2015-06-01)

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
by: Rosanna Villani, et al.
Published: (2023-03-01)

Pediatric non-alcoholic fatty liver disease
by: Delvin Edgard, et al.
Published: (2015-01-01)

Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
by: Beata Zyśk, et al.
Published: (2023-02-01)

RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)

Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
by: Chia-Jung Liao, et al.
Published: (2022-05-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Association Between Physical Activity and Prevalence/Mortality of Non-Alcoholic Fatty Liver Disease in Different Socioeconomic Settings
by: Weili Chen, et al.
Published: (2023-05-01)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
by: Patrycja Walczak, et al.
Published: (2023-01-01)

Histopathological Association of Non-alcoholic Fatty Liver Disease With Coronary Artery Atherosclerosis Grade
by: Behnaz Gholami, et al.
Published: (2024-02-01)

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
by: Xiao-Dong Zhou, et al.
Published: (2022-12-01)

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
by: Szanto KB, et al.
Published: (2019-03-01)

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
by: Christoph Roderburg, et al.
Published: (2023-04-01)

Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis
by: Karolina Jakubczyk, et al.
Published: (2020-08-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-04-01)

Comparison of Physical Activity and Fiber and Sugar Intake in Patients with Nonalcoholic Fatty Liver Disease with Healthy Individuals
by: Ammar Salehi, et al.
Published: (2020-03-01)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)

Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
by: Lanfeng Xue, et al.
Published: (2022-07-01)

Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
by: Takuro Okamura, et al.
Published: (2021-05-01)

Diagnostic Performance of Ultrasound in Detecting Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease Considering MRI Proton Density Fat Fraction as the Reference Standard
by: Ankita Aggarwal, et al.
Published: (2024-01-01)

Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Nelson Kei, et al.
Published: (2023-09-01)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Wasit Wongtrakul, et al.
Published: (2021-08-01)

Prevalence of fatty liver in metabolic syndrome
by: Anita Goyal, et al.
Published: (2020-01-01)

Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
by: Alessandro Mantovani, et al.
Published: (2022-02-01)

Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis
by: Luping Wang, et al.
Published: (2022-09-01)

Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran.
by: Bahareh Amirkalali, et al.
Published: (2014-09-01)